Physician profile
Jahnavi Devireddy
NPI 1710547732
$6,424.06
in general payments reported to CMS, 2019-2025
24 companies · $2,668 in 2025
The $2,668 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,220 · 2022: $359 · 2023: $1,358 · 2024: $819 · 2025: $2,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,463 · Travel and Lodging: $2,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,463.44 |
| Travel and Lodging | $2,381.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,007.43 | 2022-2025 | |
| Evolution Surgical, INC | $1,219.65 | 2021 | |
| Stryker Corporation | $714.08 | 2022-2025 | Augment Injectable, Flexband, Hoffmann |
| Baxter Healthcare | $294.13 | 2023-2024 | Perclot, Tisseel |
| Abbvie INC. | $204.43 | 2022-2024 | Dalvance |
| Smith+Nephew, INC. | $202.78 | 2022-2025 | Collagenase Santyl, Regranex |
| Paratek Pharmaceuticals, INC. | $116.78 | 2023-2025 | Nuzyra |
| Ets Wound Care LLC | $99.64 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Paragon 28, INC. | $85.05 | 2023 | Gorilla |
| Alafair Biosciences, INC. | $81.75 | 2023-2024 | Versawrap |
| Bioventus LLC | $48.95 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Bone Support INC. | $46.06 | 2025 | Cerament G, Ceramentbone Void Filler |
| Abbott Laboratories | $44.08 | 2025 | Eterna |
| Kerecis Limited | $31.85 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Ani Pharmaceuticals, INC. | $29.75 | 2025 | Purified Cortrophin Gel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.65 | 2024 | Krystexxa |
| Medtronic, INC. | $27.36 | 2023 | Venaseal |
| Aroa Biosurgery Incorporated | $27.02 | 2023 | |
| Grt US Holding, INC. | $22.04 | 2022 | |
| Solventum Corporation | $19.92 | 2025 | Activ.A.C., Promogran Prisma |
| Musculoskeletal Transplant Foundation INC. | $19.49 | 2023 | |
| Nevro Corp. | $18.66 | 2022 | |
| Coloplast Corp | $18.05 | 2024 | |
| Convatec INC. | $15.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jahnavi Devireddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.